RebeccaJ.ScharfMD
Pediatrics • Charlottesville, VADevelopmental-Behavioral Pediatrics
Associate Professor, Pediatrics, Neurology & Public Health, University of Virginia School of Medicine
Dr. Scharf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1204 W Main St
Charlottesville, VA 22903Phone+1 434-924-0123Fax+1 434-243-3300
Summary
- Neurodevelopmental pediatrician who has the privilege of caring for children with special medical needs. Sees patients at University of Virginia Children’s Hospital in the Pediatric Neuromuscular, Myelomeningocele, Cerebral Palsy, and Neurocardiac Clinics, as well as the International Child Development Clinic. Teaches child development, global health and epidemiology at UVA Medical School, and does research on early childhood malnutrition and developmental stimulation around the world. In Virginia, research studies include clinical trials for Duchenne Muscular Dystrophy and Spinal Muscular Atrophy.
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Developmental-Behavioral Pediatrics, 2008 - 2011
Columbia University Mailman School of Public HealthMPH, Epidemiology, 2008 - 2011
Icahn School of Medicine at Mount Sinai/Kravis Children'sResidency, Pediatrics, 2005 - 2008
State University of New York Downstate Medical Center College of MedicineClass of 2004
Certifications & Licensure
VA State Medical License 2011 - 2024
NY State Medical License 2006 - 2012- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Developmental-Behavioral Pediatrics
Clinical Trials
- Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA) Start of enrollment: 2018 Sep 25
- A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy Start of enrollment: 2022 Jun 22
- Long-Term Follow-Up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA) Start of enrollment: 2022 Jun 14
- Join now to see all
Publications & Presentations
PubMed
- 46 citationsDevelopmental Milestones.Rebecca J Scharf, Graham J Scharf, Annemarie Stroustrup
Pediatrics in Review. 2016-01-01 - 224 citationsUse of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings: Longitud...Elizabeth T. Rogawski, Jie Liu, James A Platts-Mills, Furqan Kabir, Paphavee Lertsethtakarn
The Lancet. Global Health. 2018-12-01 - 11 citationsImpact of Shigella infections and inflammation early in life on child growth and school-aged cognitive outcomes: Findings from three birth cohorts over eight years.Elizabeth T Rogawski McQuade, Rebecca J Scharf, Erling Svensen, Amber Huggins, Angelina Maphula
Plos Neglected Tropical Diseases. 2022-09-01
Press Mentions
A guide to age-appropriate chores kids can do around the houseMay 22nd, 2023
UVA Children’s Hospital Recognized for Expert Duchenne Care by Parent Project MDDecember 10th, 2018
UVA Targets Deadly Duchenne Muscular Dystrophy: Why Do Promising Treatments Fail?February 23rd, 2017- Join now to see all
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
